Kevin J. Ballinger, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 29,480 shares at $33.55 ($992K) on 2019-01-03, disclosed to the SEC on 2019-01-04.
Seasonal sale ($992k) by EVP & President, Interven Cardio — this insider has traded BSX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.55 | 12,600 | $423K | 42.6% |
| 2 | $33.55 | 12,600 | $423K | 42.6% |
| 3 | $34.21 | 2,140 | $73K | 7.4% |
| 4 | $34.21 | 2,140 | $73K | 7.4% |
| Total | $33.65 avg | 29,480 | $992K | 100% |
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |